AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10376168 — intervention group
Group type: COMPARATOR
Intervention: Sumatriptan 100 mg
Number of subjects: 156
Study 10376168 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study 10376168 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac-potassium
Number of subjects: 156
Study 9017176 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (0.2mg/Kg)
Number of subjects: 29
Study 9017176 — intervention group
Group type: COMPARATOR
Intervention: Hydroxyzine
Number of subjects: 29
Study 1736759 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Medical Research Council (MRC) scale
Number of subjects: 86
Study 1736759 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen cost diagram (OCD)
Number of subjects: 86
Study 1736759 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline dyspnea index (BDI)
Number of subjects: 86
Study 1736759 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal inspiratory (PImax) and expiratory (PEmax) mouth pressures
Number of subjects: 86
Study 1736759 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung function measures (FVC and FEV1)
Number of subjects: 86
Study 6474360 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose heparin (continuous infusion after premedication)
Number of subjects: 40
Study 6474360 — intervention group
Group type: COMPARATOR
Intervention: Control (no prophylaxis)
Number of subjects: 40
Study 6474360 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose heparin (for high-risk patients)
Number of subjects: 40
Study 6474360 — intervention group
Group type: COMPARATOR
Intervention: No prophylaxis (for low-risk patients)
Number of subjects: 40
Study 30017164 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% sodium hypochlorite solution
Number of subjects: 40
Study 30017164 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine gluconate solution
Number of subjects: 40
Study 30017164 — intervention group
Group type: COMPARATOR
Intervention: water (placebo)
Number of subjects: 40
Study 30017164 — intervention group
Group type: COMPARATOR
Intervention: 5% sodium bicarbonate solution
Number of subjects: 40
Study 29732731 — intervention group
Group type: EXPERIMENTAL
Intervention: SAR100842
Number of subjects: 32
Study 29732731 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 27168135 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (30 min moderate-intensity stationary bicycle exercise)
Number of subjects: 14
Study 27168135 — intervention group
Group type: COMPARATOR
Intervention: Rest
Number of subjects: 14
Study 27168135 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 14
Study 24178185 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunomodulating enteral nutrition (IMEN)
Number of subjects: 776
Study 24178185 — intervention group
Group type: COMPARATOR
Intervention: Standard enteral nutrition (SEN)
Number of subjects: 776
Study 24178185 — intervention group
Group type: COMPARATOR
Intervention: Standard parenteral nutrition (SPN)
Number of subjects: 776
Study 24178185 — intervention group
Group type: COMPARATOR
Intervention: Immunomodulating parenteral nutrition (IMPN)
Number of subjects: 776
Study 23740043 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% flow decrease
Number of subjects: 34
Study 23740043 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% flow decrease with phenylephrine to restore baseline pressure
Number of subjects: 34
Study 23740043 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased flow with baseline pressure
Number of subjects: 34
Study 23740043 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% pressure decrease with sodium nitroprusside (SNP) under baseline flow
Number of subjects: 34
Study 20803859 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior approach sciatic nerve block
Number of subjects: 120
Study 20803859 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral approach sciatic nerve block
Number of subjects: 120
Study 20803859 — intervention group
Group type: COMPARATOR
Intervention: Posterior parasacral approach sciatic nerve block
Number of subjects: 120
Study 20803859 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous nerve block (all approaches)
Number of subjects: 120
Study 18959455 — intervention group
Group type: EXPERIMENTAL
Intervention: Live music therapy sessions (pre and postoperative)
Number of subjects: 27
Study 18959455 — intervention group
Group type: COMPARATOR
Intervention: Control group (no music intervention)
Number of subjects: 27
Study 15725984 — intervention group
Group type: EXPERIMENTAL
Intervention: Handout survey
Number of subjects: 0
Study 15725984 — intervention group
Group type: COMPARATOR
Intervention: Mailed survey
Number of subjects: 0
Study 12840089 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized epinephrine (1 percent, 4 ml doses)
Number of subjects: 194
Study 12840089 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline, 4 ml doses)
Number of subjects: 194
Study 11197923 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational family intervention plus individual psychosocial treatment
Number of subjects: 40
Study 11197923 — intervention group
Group type: COMPARATOR
Intervention: Individual psychosocial treatment
Number of subjects: 40
Study 9275608 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotation advancement method
Number of subjects: 126
Study 9275608 — intervention group
Group type: COMPARATOR
Intervention: Triangular flap method
Number of subjects: 126
Study 2003340 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ofloxacin
Number of subjects: 72
Study 2003340 — intervention group
Group type: COMPARATOR
Intervention: Intravenous ceftazidime
Number of subjects: 72
Study 6396120 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifonazole cream applied once or twice daily
Number of subjects: 275
Study 6396120 — intervention group
Group type: EXPERIMENTAL
Intervention: Clotrimazole applied twice daily
Number of subjects: 275
Study 6396120 — intervention group
Group type: COMPARATOR
Intervention: Placebo applied twice daily
Number of subjects: 275
Study 30764582 — intervention group
Group type: EXPERIMENTAL
Intervention: Hibiscus sabdariffa calyces (HSC) extract (250 mL)
Number of subjects: 25
Study 30764582 — intervention group
Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 25
Study 30213037 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-reduced high-protein (CRHP) diet
Number of subjects: 14
Study 27502808 — intervention group
Group type: COMPARATOR
Intervention: Heat therapy
Number of subjects: 90
Study 27502808 — intervention group
Group type: COMPARATOR
Intervention: Birth ball
Number of subjects: 90
Study 25089931 — intervention group
Group type: EXPERIMENTAL
Intervention: IL1RN variant rs315952C
Number of subjects: 294
Study 22420698 — intervention group
Group type: EXPERIMENTAL
Intervention: DATE program (Dating Assertiveness Training Experience)
Number of subjects: 139
Study 22420698 — intervention group
Group type: COMPARATOR
Intervention: Control group (no-treatment)
Number of subjects: 139
Study 20830731 — intervention group
Group type: EXPERIMENTAL
Intervention: GAD-alum (20 μg, two injections)
Number of subjects: 70
Study 20830731 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 18402096 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioning of the enamel with 38% phosphoric acid (group 1)
Number of subjects: 63
Study 18402096 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioning with phosphoric acid and single-bottle dentin bonding agent (group 2)
Number of subjects: 63
Study 18402096 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioning with a self-etching adhesive (group 3)
Number of subjects: 63
Study 15850080 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline
Number of subjects: 104
Study 15850080 — intervention group
Group type: EXPERIMENTAL
Intervention: Faces task
Number of subjects: 104
Study 15850080 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentences task
Number of subjects: 104
Study 15850080 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery
Number of subjects: 104
Study 15850080 — intervention group
Group type: EXPERIMENTAL
Intervention: Older adults
Number of subjects: 104
Study 12698306 — intervention group
Group type: EXPERIMENTAL
Intervention: Diosmin 500 mg once daily for 9 days before metronidazole administration
Number of subjects: 12
Study 12698306 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole 400 mg (two tablets) administered after diosmin pretreatment
Number of subjects: 12
Study 12698306 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole 400 mg (two tablets) administered alone (no diosmin pretreatment)
Number of subjects: 12
Study 10481832 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (5 micrograms/kg, p.o.)
Number of subjects: 0
Study 10481832 — intervention group
Group type: EXPERIMENTAL
Intervention: Guanfacine (29 micrograms/kg, p.o.)
Number of subjects: 0
Study 10481832 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8354373 — intervention group
Group type: EXPERIMENTAL
Intervention: Contraceptive sponge
Number of subjects: 2833
Study 8354373 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical cap
Number of subjects: 2833
Study 8354373 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaphragm
Number of subjects: 2833
Study 8354373 — intervention group
Group type: EXPERIMENTAL
Intervention: Contraceptive sponge (post-birth)
Number of subjects: 2833
Study 8354373 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical cap (post-birth)
Number of subjects: 2833
Study 8354373 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaphragm (post-birth)
Number of subjects: 2833
Study 3789514 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaphragmatic fatiguing contractions
Number of subjects: 6
Study 3789514 — intervention group
Group type: COMPARATOR
Intervention: Diaphragmatic nonfatiguing contractions
Number of subjects: 6
Study 28745063 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based step training using videogame technology
Number of subjects: 60
Study 28745063 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 27681702 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine patch (5 cm2 [4.6 mg/24 h], 10 cm2 [9.5 mg/24 h], 15 cm2 [13.3 mg/24 h], and 20 cm2 [17.4 mg/24 h])
Number of subjects: 0
Study 27681702 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine capsule (1.5, 3, 4.5, and 6 mg/12 h)
Number of subjects: 0
Study 27681702 — intervention group
Group type: EXPERIMENTAL
Intervention: Model-based estimates of plasma concentrations adjusted for body weight
Number of subjects: 0
Study 27681702 — intervention group
Group type: COMPARATOR
Intervention: Renal function (mild/no vs. moderate/severe/end-stage)
Number of subjects: 0
Study 26560820 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined headgear (CH)
Number of subjects: 61
Study 26560820 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined headgear + rapid maxillary expansion (CH + RME)
Number of subjects: 61
Study 26560820 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 61
Study 23445266 — intervention group
Group type: EXPERIMENTAL
Intervention: Intercostal nerve blockade with 20 mL of 0.5% bupivacaine with epinephrine
Number of subjects: 63
Study 23445266 — intervention group
Group type: COMPARATOR
Intervention: Placebo (20 mL physiologic saline)
Number of subjects: 63
Study 21465735 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-minute IV infusion of zoledronic acid 4 mg (in 250 mL)
Number of subjects: 176
Study 21465735 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-minute IV infusion of zoledronic acid 4 mg (in 250 mL)
Number of subjects: 176
Study 20005647 — intervention group
Group type: EXPERIMENTAL
Intervention: Dydrogesterone (40 mg stat followed by 10 mg twice daily)
Number of subjects: 191
Study 20005647 — intervention group
Group type: COMPARATOR
Intervention: Conservative management (control group)
Number of subjects: 191
Study 16979453 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient phone call to assess smoking status, quit challenges, and treatment preferences, and computerized progress note to providers communicating this information
Number of subjects: 1900
Study 16979453 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1900
Study 15343587 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin (0.05 units/kg)
Number of subjects: 16
Study 15343587 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 16
Study 10942153 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole, 200 mg p.o., 3‐4 h before surgery
Number of subjects: 21
Study 10942153 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 10349448 — intervention group
Group type: EXPERIMENTAL
Intervention: Heberbiovac‐HB (0 and 2 months)
Number of subjects: 0
Study 10349448 — intervention group
Group type: EXPERIMENTAL
Intervention: Heberbiovac‐HB (0 and 4 months)
Number of subjects: 0
Study 10349448 — intervention group
Group type: EXPERIMENTAL
Intervention: Heberbiovac‐HB (0 and 6 months)
Number of subjects: 0
Study 10349448 — intervention group
Group type: EXPERIMENTAL
Intervention: Heberbiovac‐HB (0 and 8 months)
Number of subjects: 0
Study 10349448 — intervention group
Group type: COMPARATOR
Intervention: Control group (0, 1 and 6 months)
Number of subjects: 0
Study 7518932 — intervention group
Group type: EXPERIMENTAL
Intervention: Strontium-89 (200 MBq)
Number of subjects: 284
Study 7518932 — intervention group
Group type: COMPARATOR
Intervention: Hemibody radiotherapy
Number of subjects: 284
Study 7518932 — intervention group
Group type: COMPARATOR
Intervention: Local radiotherapy
Number of subjects: 284
Study 7518932 — intervention group
Group type: EXPERIMENTAL
Intervention: Strontium-89
Number of subjects: 284
Study 2498074 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ) suspension administered orally after an overnight fast
Number of subjects: 8
Study 2498074 — intervention group
Group type: COMPARATOR
Intervention: Carbamazepine (CBZ) suspension administered by nasogastric feeding tube during continuous enteral feeding infusion
Number of subjects: 8
Study 31868055 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% benzoyl peroxide
Number of subjects: 89
Study 31868055 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% benzoyl peroxide
Number of subjects: 89
Study 30408325 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucoraphanin-rich (GRR) beverage
Number of subjects: 50
Study 30408325 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulforaphane-rich (SFR) beverage
Number of subjects: 50
Study 30408325 — intervention group
Group type: EXPERIMENTAL
Intervention: Broccoli beverage consumption
Number of subjects: 50
Study 30408325 — intervention group
Group type: EXPERIMENTAL
Intervention: Rats administered 100 µmol kg-1 SFN
Number of subjects: 50
Study 30408325 — intervention group
Group type: EXPERIMENTAL
Intervention: TTCA
Number of subjects: 50
Study 27050109 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness intervention (baseline mindfulness scores)
Number of subjects: 140
Study 27050109 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet and exercise intervention
Number of subjects: 140
Study 27050109 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline total FFMQ score
Number of subjects: 140
Study 27050109 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline body weight
Number of subjects: 140
Study 25092681 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary tirofiban
Number of subjects: 162
Study 25092681 — intervention group
Group type: COMPARATOR
Intervention: Intracoronary placebo
Number of subjects: 162
Study 23201035 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin (OT)
Number of subjects: 0
Study 22000430 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal synchronized intermittent positive pressure ventilation (NSIPPV)
Number of subjects: 80
Study 22000430 — intervention group
Group type: COMPARATOR
Intervention: Nasal continuous positive airway pressure ventilation (NCPAP)
Number of subjects: 80
Study 18454661 — intervention group
Group type: EXPERIMENTAL
Intervention: Locally delivered doxycycline gel at baseline and 1 and 2 years as an adjunct to mechanical debridement
Number of subjects: 128
Study 18454661 — intervention group
Group type: COMPARATOR
Intervention: Mechanical debridement only
Number of subjects: 128
Study 16511917 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of cyclosporine (CSA) and leflunomide (LEF)
Number of subjects: 106
Study 16511917 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine (CSA)
Number of subjects: 106
Study 16511917 — intervention group
Group type: COMPARATOR
Intervention: Leflunomide (LEF)
Number of subjects: 106
Study 14535175 — intervention group
Group type: EXPERIMENTAL
Intervention: Softening and lubricating the joints, and calming the endogenous wind
Number of subjects: 60
Study 14535175 — intervention group
Group type: COMPARATOR
Intervention: Zheng Qing Feng Tong Ning Tablets
Number of subjects: 60
Study 11136411 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing intervention program designed to enhance hope
Number of subjects: 115
Study 11136411 — intervention group
Group type: COMPARATOR
Intervention: Attention control group (informational)
Number of subjects: 115
Study 11136411 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual treatment)
Number of subjects: 115
Study 8936563 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg itraconazole orally once daily for 10 days
Number of subjects: 10
Study 8936563 — intervention group
Group type: COMPARATOR
Intervention: Placebo orally once daily for 10 days
Number of subjects: 10
Study 8464611 — intervention group
Group type: EXPERIMENTAL
Intervention: Mucin-containing lozenge
Number of subjects: 42
Study 8464611 — intervention group
Group type: COMPARATOR
Intervention: Placebo lozenge
Number of subjects: 42
Study 3456972 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (2 X 50 mg daily)
Number of subjects: 8
Study 3456972 — intervention group
Group type: EXPERIMENTAL
Intervention: Carprofen (2 X 150 mg daily)
Number of subjects: 8
Study 29063389 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief psychosocial intervention training for health professionals
Number of subjects: 20
Study 27793949 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorafenib plus percutaneous radiofrequency ablation (RFA) of both HCC and PVTT
Number of subjects: 99
Study 27793949 — intervention group
Group type: COMPARATOR
Intervention: Sorafenib alone
Number of subjects: 99
Study 23482473 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg once daily for 6 weeks
Number of subjects: 111
Study 23482473 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study 23482473 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg twice daily for 12 weeks
Number of subjects: 111
Study 23482473 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin versus placebo
Number of subjects: 111
Study 22322357 — intervention group
Group type: EXPERIMENTAL
Intervention: BGP-15
Number of subjects: 0
Study 20499249 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 g L‐citrulline‐malate 2 h prior to exercise
Number of subjects: 17
Study 20499249 — intervention group
Group type: COMPARATOR
Intervention: Control group (no supplementation)
Number of subjects: 17
Study 19230597 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (CFX) 500 mg
Number of subjects: 0
Study 19230597 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (IBF) 400 mg
Number of subjects: 0
Study 19230597 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 16044790 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional evaluation methods (cross‐sectional studies, observational studies, comparative studies, randomised controlled trials, and metaanalyses) applied to complementary and alternative medicine
Number of subjects: 0
Study 11850711 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgrastim
Number of subjects: 156
Study 11850711 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential sargramostim and filgrastim
Number of subjects: 156
Study 11850711 — intervention group
Group type: COMPARATOR
Intervention: Sargramostim
Number of subjects: 156
Study 10361400 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 20
Study 10361400 — intervention group
Group type: COMPARATOR
Intervention: Reading control
Number of subjects: 20
Study 9457977 — intervention group
Group type: EXPERIMENTAL
Intervention: Untreated cervicitis (Group C)
Number of subjects: 0
Study 9457977 — intervention group
Group type: EXPERIMENTAL
Intervention: Chorioamnionitis
Number of subjects: 0
Study 9457977 — intervention group
Group type: EXPERIMENTAL
Intervention: PROM (Premature Rupture of Membranes)
Number of subjects: 0
Study 9457977 — intervention group
Group type: COMPARATOR
Intervention: Treated cervicitis (Group B)
Number of subjects: 0
Study 9457977 — intervention group
Group type: COMPARATOR
Intervention: Controls (Group A)
Number of subjects: 0
Study 1781005 — intervention group
Group type: EXPERIMENTAL
Intervention: Norfloxacin (7 days, twice daily)
Number of subjects: 40
Study 1781005 — intervention group
Group type: COMPARATOR
Intervention: Chloramphenicol (14 days)
Number of subjects: 40
Study 7450954 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient psychotherapy with urine surveillance
Number of subjects: 29
Study 7450954 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient psychotherapy without urine surveillance
Number of subjects: 29
Study 7450954 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 29
Study 30040026 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-degrees rightward deviation
Number of subjects: 4
Study 30040026 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-degrees rightward deviation
Number of subjects: 4
Study 30040026 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-degrees rightward deviation
Number of subjects: 4
Study 30040026 — intervention group
Group type: COMPARATOR
Intervention: No deviation
Number of subjects: 4
Study 29497768 — intervention group
Group type: EXPERIMENTAL
Intervention: all-seeing needle micro-PCNL
Number of subjects: 116
Study 29497768 — intervention group
Group type: COMPARATOR
Intervention: FURS
Number of subjects: 116
Study 27903136 — intervention group
Group type: EXPERIMENTAL
Intervention: Ending Self‐Stigma (ESS) psychoeducational intervention, 9 weeks duration
Number of subjects: 268